Biography

Qian Qin, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology and Oncology. She specializes in bladder, kidney, prostate, and testicular cancer.

I really enjoy taking part in the multidisciplinary, patient-centered care and the robust research programs available at UT Southwestern.

Originally from Houston, Texas, Dr. Qin holds a bachelor's degree in biological sciences and Asian studies from Rice University, where she graduated magna cum laude. She earned her medical degree from Baylor College of Medicine, and completed internal medicine residency training at Houston Methodist Hospital. She then gained advanced training through a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai in New York.

Certified by the Board of Internal Medicine, she joined the UT Southwestern faculty in 2021.

Dr. Qin’s research interests include novel biomarkers, therapeutics, and therapeutic combinations in genitourinary cancers, particularly in the context of clinical trials. 

Dr. Qin is a member of the American Medical Association and the American Society of Clinical Oncology. She has published numerous academic articles and delivered several presentations.

Personal Note

Outside of medicine, Dr. Qin enjoys spending time with her family, exploring the great outdoors, and designing interior spaces.

 

Education

Medical School
Baylor College of Medicine (2015)
Internship
Houston Methodist Hospital (2016)
Residency
Houston Methodist Hospital (2018), Internal Medicine
Fellowship
Icahn School of Medicine at Mount Sinai (2021), Hematology Oncology

Research Interest

  • Industy and Cooperative Group-sponsored Trials in Genitourinary Oncology
  • Investigator-initiated Clinical Trials in Genitourinary Oncology
  • Novel Biomarkers, Therapeutics, and Therapeutic Combinations in Genitourinary Oncology

Publications

Featured Publications LegendFeatured Publications

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Lung Cancer 2021 Jul 160 78-83
Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging?
Bikkasani K, Qin Q, Zhong X, Lin J, Galsky MD, Oh WK, Tsao CK, Clin Genitourin Cancer 2021 Apr
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.
Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK, Am J Clin Oncol 2021 03 44 3 114-120
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Cancer Cell 2020 Dec 38 6 769-770
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D, Thromb Res 2020 12 196 99-105
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L, Blood 2020 Jul 136 1 144-147
Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.
Qin Q, Patel V, Galsky MD, Expert Rev Anticancer Ther 2020 06 20 6 503-512
Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma.
Qin Q, Nan X, Miller T, Fisher R, Teh B, Pandita S, Farach AM, Pingali SR, Pandita RK, Butler EB, Pandita TK, Iyer SP Radiat. Res. 2018 Jun
Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X, Qin Q, Gentille C, Ensor J, Leveque C, Pingali SR, Phan AT, Rice L, Iyer S Leuk. Lymphoma 2017 Jan 1-11
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.
Qin Q, Xu Y, He T, Qin C, Xu J, Cell Res 2012 Jan 22 1 90-106

Honors & Awards

  • Eugene P. Frenkel, M.D., Endowed Scholar Award in Clinical Medicine
    UT Southwestern (2022)
  • Second Place, Clinical Vignette Poster Presentation
    American College of Physicians, Southeast Region (2016)
  • Second Place, Research Poster Presentation
    American College of Physicians, Southeast Region (2016)

Professional Associations/Affiliations

  • American Medical Association
  • American Society of Clinical Oncology
  • American Society of Hematology
  • Caris Precision Oncology Alliance, Genitourinary Group
  • Caris Precision Oncology Alliance, Genitourinary Group
  • Chinese American Hematologist and Oncologist Network
  • Dallas County Medical Society
  • Eastern Cooperative Oncology Group, Genitourinary Working Group
  • European Society of Medical Oncology
  • Hoosier Cancer Research Network, Genitourinary Working Group
  • Texas Medical Association